Business Context and Reporting Period
This Form 6-K filing by BiondVax Pharmaceuticals Ltd. (referred to in metadata as Scinai Immunotherapeutics Ltd.) covers the month of January 2017. The report details a corporate administrative change regarding the management of shareholder records.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report of a specific corporate event and does not contain financial statements.
Material Changes
On January 25, 2017, the Company engaged Mizrahi Tefahot Bank Registration Company Ltd. to serve as its registrar. This entity will maintain records for publicly traded ordinary shares and tradable options (Series 4 and Series 5) on the Tel Aviv Stock Exchange. Mizrahi Tefahot replaces Bank Leumi Registration Company Ltd., which ceased operations in August 2015.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the operational transition of the registrar.
Investor Verification Checklist
- Confirm the effective date of the registrar transition to Mizrahi Tefahot Bank Registration Company Ltd.
- Verify the status of tradable options (Series 4 and Series 5) under the new registrar.
- Check for any subsequent filings regarding the cessation of Bank Leumi Registration Company Ltd.'s services.